{"transactions":[{"id":4084874,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc.","position":1,"cik":"0001619856","reported_name":"Caribou Biosciences, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-30T22:28:28.000Z","date":"2018-01-29","kind":"sale","acquired":false,"shares":550645,"price":26.78,"value":14746273.1,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.75 to $26.97, inclusive.  The reporting person undertakes to provide to Intellia Therapeutics, Inc., any security holder of Intellia Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is filed on behalf of (i) Caribou Therapeutics Holdco, LLC, the direct holder of the shares, and (ii) Caribou Biosciences, Inc.  Caribou Therapeutics Holdco, LLC is a wholly-owned subsidiary of Caribou Biosciences, Inc., and thus Caribou Biosciences, Inc. may be deemed to share voting and dispositive power with respect to the shares held by Caribou Therapeutics Holdco, LLC.  Caribou Biosciences, Inc. disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, if any."}],"balance_after":3994355,"source":{"system":"sec-edgar","filing":"0001415889-18-000152","document":"form4-01302018_020115.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000141588918000152/form4-01302018_020115.xml","form_type":"4"}},{"id":4210439,"issuer":{"id":4585,"kind":"organization","name":"Intellia Therapeutics, Inc.","symbol":"NTLA"},"owners":[{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc.","position":1,"cik":"0001619856","reported_name":"Caribou Biosciences, Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-13T22:29:58.000Z","date":"2017-09-13","kind":"sale","acquired":false,"shares":1048846,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transfer of stock relates to the Exclusive License Agreement, by and among Caribou Biosciences, Inc., The Regents of the University of California, and the University of Vienna, dated April 16, 2013."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is filed on behalf of (i) Caribou Therapeutics Holdco, LLC, the direct holder of the shares, and (ii) Caribou Biosciences, Inc. Caribou Therapeutics Holdco, LLC is a wholly-owned subsidiary of Caribou Biosciences, Inc., and thus Caribou Biosciences, Inc. may be deemed to share voting and dispositive power with respect to the shares held by Caribou Therapeutics Holdco, LLC. Caribou Biosciences, Inc. disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, if any."}],"balance_after":4545000,"source":{"system":"sec-edgar","filing":"0001415889-17-001484","document":"form4-09132017_030948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652130/000141588917001484/form4-09132017_030948.xml","form_type":"4"}}]}